2 unknown, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 2, Completed 1 |
Follow GHD: new trials by email Literature Review of GHD trials Research Report on GHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency GenSci004, Genotropin - GHD | Phase 3 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 162 | 2023-12-01 | 2023-09-11 |
| A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency PEG-somatropin - GHD | Phase 3 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 180 | 2023-12-01 | 2023-09-11 |
| Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity Recombinant GH Saizen (Merck-Serono) - Obesity, GHD | Phase 3 | Completed | Federico II University | 24 | 2007-07-01 | 2008-03-28 |
Dwarfism, Pituitary (3) · Obesity (1)
Bone Diseases (3) · Bone Diseases, Developmental (3) · Bone Diseases, Endocrine (3) · Brain Diseases (3) · Central Nervous System Diseases (3) · Dwarfism (3) · Endocrine System Diseases (3) · Hypopituitarism (3) · Hypothalamic Diseases (3) · Musculoskeletal Diseases (3) · Nervous System Diseases (3) · Pituitary Diseases (3) · Body Weight (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1)
Changchun GeneScience Pharmaceutical Co., Ltd. (2) · Federico II University (1)
Italy (1) · United States (1)
Annamaria Colao, MD, PhD (1) · Bradley Miller (1) · Lawrence Silverman, MD (1)